IDEXX LABORATORIES INC /DE - Common Stock (IDXX) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
IDXX on Nasdaq
Shares outstanding
80,841,255
Price per share
$676.53
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
71,945,340
Total reported value
$45,941,105,840
% of total 13F portfolios
0.04%
Share change
-2,397,886
Value change
-$1,426,822,413
Number of holders
1,282
Price from insider filings
$676.53
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of IDEXX LABORATORIES INC /DE - Common Stock (IDXX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 9.4% $2,901,555,953 7,599,078 BlackRock, Inc. 31 Mar 2025

As of 30 Sep 2025, 1,282 institutional investors reported holding 71,945,340 shares of IDEXX LABORATORIES INC /DE - Common Stock (IDXX). This represents 89% of the company’s total 80,841,255 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of IDEXX LABORATORIES INC /DE - Common Stock (IDXX) together control 57% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 12% 9,962,025 +0.87% 0.1% $6,364,638,153
BlackRock, Inc. 10% 8,205,011 -2% 0.09% $5,242,099,447
STATE STREET CORP 4.4% 3,517,670 -1% 0.08% $2,247,404,186
Fundsmith LLP 3.2% 2,610,457 -1.1% 8.4% $1,667,794,873
GEODE CAPITAL MANAGEMENT, LLC 3.1% 2,497,676 +1.4% 0.1% $1,591,098,712
Bank of New York Mellon Corp 2.5% 2,056,680 +42% 0.24% $1,313,992,065
BAMCO INC /NY/ 2.3% 1,884,129 -7.3% 3.2% $1,203,751,177
MORGAN STANLEY 2% 1,622,490 -2.5% 0.06% $1,036,595,623
Invesco Ltd. 1.6% 1,320,263 +14% 0.13% $843,502,663
PRINCIPAL FINANCIAL GROUP INC 1.6% 1,315,722 +17% 0.42% $840,638,344
POLEN CAPITAL MANAGEMENT LLC 1.4% 1,127,147 -5.7% 2.3% $720,123,065
BLAIR WILLIAM & CO/IL 1.3% 1,031,786 -4.5% 1.8% $659,197,463
NORTHERN TRUST CORP 1.2% 942,368 -1.5% 0.08% $602,069,492
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC 1.1% 875,549 -18% 0.12% $559,379,500
JPMORGAN CHASE & CO 1.1% 869,930 +60% 0.04% $555,801,572
GOLDMAN SACHS GROUP INC 0.88% 711,942 +21% 0.07% $454,852,946
AMERICAN CENTURY COMPANIES INC 0.87% 705,158 -17% 0.23% $450,518,395
PRICE T ROWE ASSOCIATES INC /MD/ 0.86% 694,208 +29% 0.05% $443,524,000
Capital Research Global Investors 0.85% 690,601 +0.82% 0.08% $441,218,073
FUNDSMITH INVESTMENT SERVICES LTD. 0.85% 688,357 -19% 6.9% $439,784,404
Legal & General Group Plc 0.84% 675,535 +4.1% 0.1% $431,592,555
Amundi 0.73% 592,599 -12% 0.12% $372,021,801
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.71% 575,930 +3.5% 0.06% $367,955,918
FRANKLIN RESOURCES INC 0.71% 572,978 -3.3% 0.09% $366,069,631
DIMENSIONAL FUND ADVISORS LP 0.67% 544,185 -2.3% 0.07% $347,641,219

Institutional Holders of IDEXX LABORATORIES INC /DE - Common Stock (IDXX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 751,941 $509,684,885 +$92,878,677 $676.53 85
2025 Q3 71,945,340 $45,941,105,840 -$1,426,822,413 $638.89 1,282
2025 Q2 74,492,454 $39,944,909,126 +$622,390,391 $536.34 1,224
2025 Q1 73,614,871 $30,895,590,103 +$783,052,148 $419.95 1,124
2024 Q4 71,698,049 $29,668,366,358 -$542,112,501 $413.44 1,100
2024 Q3 71,722,534 $36,168,375,599 -$1,429,561,827 $505.22 1,098
2024 Q2 74,809,187 $36,439,975,016 +$1,678,522,290 $487.20 1,090
2024 Q1 71,636,936 $38,605,061,886 -$654,012,730 $539.93 1,134
2023 Q4 618,689 $343,418,084 -$71,482,869 $555.05 17
2023 Q3 73,027,374 $31,929,588,162 +$380,630,545 $437.27 1,039
2023 Q2 72,065,654 $36,176,750,229 -$361,041,033 $502.23 1,043
2023 Q1 71,505,625 $35,738,476,312 -$335,067,699 $500.08 1,025
2022 Q4 73,328,314 $29,942,359,198 +$152,565,360 $407.96 964
2022 Q3 69,833,455 $22,767,069,291 +$96,661,228 $325.80 871
2022 Q2 73,548,758 $25,791,566,310 +$442,557,426 $350.73 920
2022 Q1 72,044,210 $39,392,262,274 +$494,091,566 $547.06 995
2021 Q4 70,173,184 $46,133,818,299 -$186,640,870 $658.46 1,071
2021 Q3 62,789,805 $39,048,926,778 -$1,156,298,722 $621.90 1,042
2021 Q2 71,992,572 $45,462,586,279 +$134,947,712 $631.55 1,011
2021 Q1 72,202,421 $35,326,218,339 -$386,930,873 $489.31 995
2020 Q4 73,496,456 $36,716,345,277 +$244,994,598 $499.87 946
2020 Q3 65,500,805 $25,726,737,674 -$683,503,489 $393.11 828
2020 Q2 66,173,293 $21,845,916,428 -$238,235,357 $330.16 780
2020 Q1 75,464,992 $18,278,917,910 +$317,646,961 $242.24 731
2019 Q4 74,331,536 $19,408,671,560 -$136,608,724 $261.13 736
2019 Q3 74,812,102 $20,341,884,422 -$166,005,051 $271.93 705
2019 Q2 74,574,799 $20,530,912,213 +$338,134,331 $275.33 694
2019 Q1 75,605,325 $16,905,413,347 +$141,740,000 $223.60 666
2018 Q4 70,793,046 $13,169,116,048 +$173,174,175 $186.02 655
2018 Q3 74,198,801 $18,521,962,311 -$145,401,937 $249.66 682
2018 Q2 79,539,686 $17,333,684,464 -$17,851,947 $217.94 651
2018 Q1 75,299,447 $14,408,368,610 +$29,882,248 $191.39 635
2017 Q4 76,278,322 $11,926,489,935 -$2,291,880,498 $156.38 603
2017 Q3 71,899,393 $11,179,358,434 -$66,722,399 $155.49 565
2017 Q2 76,985,043 $12,428,178,061 -$168,019,755 $161.42 572
2017 Q1 78,677,171 $12,157,982,005 +$1,320,542,392 $154.61 528
2016 Q4 78,002,741 $9,151,021,342 -$400,760,404 $117.27 510
2016 Q3 81,568,872 $9,191,319,499 -$94,151,684 $112.73 466
2016 Q2 81,629,832 $7,580,096,605 -$374,524,898 $92.86 428
2016 Q1 86,897,438 $6,804,507,287 -$230,890,228 $78.32 367
2015 Q4 88,665,740 $6,465,235,487 -$74,454,545 $72.92 342
2015 Q3 90,783,033 $6,739,334,682 -$82,001,035 $74.25 349
2015 Q2 89,767,287 $5,757,538,294 +$2,810,221,238 $64.14 344
2015 Q1 44,784,964 $6,914,660,385 -$72,802,160 $154.48 339
2014 Q4 46,302,363 $6,868,103,193 -$170,176,575 $148.27 345
2014 Q3 47,689,506 $5,619,296,343 -$92,027,043 $117.83 313
2014 Q2 48,342,928 $6,456,581,609 -$301,107,262 $133.57 305
2014 Q1 50,628,842 $6,146,282,012 -$72,423,259 $121.40 311